LifeStance Health Group Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	23.2	9.66	-57.44	-186.26	-215.56	-307.2
Depreciation & Amortization	54.32	54.75	70.95	80.44	69.2	54.14
Stock-Based Compensation	71.32	74.7	76.17	99.39	187.43	259.44
Other Adjustments	45.21	47.38	44.95	23.28	28.66	0.9
Change in Receivables	17.71	36.09	-6.4	-24.18	-21.66	-24.21
Changes in Accounts Payable	-2.5	-1.56	0.5	-5.61	7.67	0.62
Changes in Accrued Expenses	25.26	19.94	28.61	36.69	13.66	54.85
Changes in Other Operating Activities	-54.58	-94.81	-50.08	-40.63	-16.6	-29.12
Operating Cash Flow	182.35	146.15	107.26	-16.88	52.79	9.42
Operating Cash Flow Growth	44.72%	36.26%	-	-	460.39%	-
Capital Expenditures	-39.72	-36.13	-21.57	-40.52	-79.26	-94.49
Payments for Business Acquisitions	-3.14	-	-	-19.82	-60.21	-99.58
Investing Cash Flow	-42.87	-36.13	-21.57	-60.34	-139.46	-194.08
Long-Term Debt Issued	-	-	287.81	57.75	257.32	98.8
Long-Term Debt Repaid	-5.44	-7.25	-289.49	-2.47	-189.38	-320.21
Net Long-Term Debt Issued (Repaid)	-5.44	-7.25	-1.69	55.28	67.95	-221.41
Issuance of Common Stock	-	-	-	-	-	549.91
Repurchase of Common Stock	-49.11	-	-	-	-	-
Net Common Stock Issued (Repurchased)	-49.11	-	-	-	-	549.91
Other Financing Activities	-24.48	-8.71	-8.26	-7.86	-20.69	-14.64
Financing Cash Flow	-79.02	-15.96	-9.95	47.43	47.26	313.86
Net Cash Flow	60.46	94.07	75.75	-29.8	-39.41	129.2
Free Cash Flow	142.63	110.03	85.69	-57.4	-26.47	-85.07
Free Cash Flow Growth	29.63%	28.39%	-	-	-	-
FCF Margin	9.54%	7.72%	6.85%	-5.44%	-3.08%	-12.74%
Free Cash Flow Per Share	0.36	0.28	0.23	-0.16	-0.07	-0.26
Levered Free Cash Flow	-26.46	-55.4	-30.71	-100.61	-152.95	-579.36
Unlevered Free Cash Flow	13.95	-38.93	-3.11	-140.16	-200	-278.08

SEC Filings: 10-K · 10-Q